{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T21:19:36Z","timestamp":1790543976487,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T00:00:00Z","timestamp":1613088000000},"content-version":"am","delay-in-days":408,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004324","name":"Astellas Pharma US","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004324","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007054","name":"Meso Scale Diagnostics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.bulcan.2019.11.002","type":"journal-article","created":{"date-parts":[[2019,12,7]],"date-time":"2019-12-07T00:22:36Z","timestamp":1575678156000},"page":"S104-S113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"S","title":["Indications de l\u2019autogreffe de cellules souches h\u00e9matopo\u00ef\u00e9tiques dans la polyradiculon\u00e9vrite inflammatoire d\u00e9my\u00e9linisante chronique\u00a0: recommandations de la Soci\u00e9t\u00e9 francophone de greffe de moelle et de th\u00e9rapie cellulaire (SFGM-TC)"],"prefix":"10.1016","volume":"107","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5639-0138","authenticated-orcid":false,"given":"Mathieu","family":"Puyade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Labeyrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Badoglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Cintas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Guenounou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Lansiaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zora","family":"Marjanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Nicolas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Am\u00e9lie","family":"Pomies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Terriou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose-Miguel","family":"Torregrosa Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9ment","family":"Baron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Castilla Llorente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Yakoub-Agha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4041-1352","authenticated-orcid":false,"given":"Dominique","family":"Farge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bulcan.2019.11.002_bib0220","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S1474-4422(10)70041-7","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy: diagnostic and therapeutic challenges for a treatable condition","volume":"9","author":"Vallat","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.bulcan.2019.11.002_bib0225","first-page":"1","volume":"15","year":"2010","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.bulcan.2019.11.002_bib0230","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1529-8027.2010.00251.x","article-title":"A current view of the diagnosis, clinical variants, response to treatment and prognosis of chronic inflammatory demyelinating polyradiculoneuropathy","volume":"15","author":"Viala","year":"2010","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.bulcan.2019.11.002_bib0235","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1212\/WNL.41.5.617","article-title":"Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force","volume":"41","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.bulcan.2019.11.002_bib0240","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1136\/jnnp.2005.081547","article-title":"A modified peripheral neuropathy scale: the Overall Neuropathy Limitations Scale","volume":"77","author":"Graham","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.bulcan.2019.11.002_bib0245","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1161\/01.STR.0000258355.23810.c6","article-title":"Outcomes Validity and Reliability of the Modified Rankin Scale: Implications for Stroke Clinical Trials: A Literature Review and Synthesis","volume":"38","author":"Banks","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.bulcan.2019.11.002_bib0250","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/mus.880141111","article-title":"Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barr\u00e9 syndrome: Muscle Strength Assessment in GBS","volume":"14","author":"Kleyweg","year":"1991","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.bulcan.2019.11.002_bib0255","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1212\/WNL.54.4.943","article-title":"Psychometric evaluation of a new sensory scale in immune-mediated polyneuropathies. Inflammatory Neuropathy Cause and Treatment (INCAT) Group","volume":"54","author":"Merkies","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.bulcan.2019.11.002_bib0260","first-page":"919","article-title":"The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure","volume":"132","author":"Guyatt","year":"1985","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.bulcan.2019.11.002_bib0265","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s004010050941","article-title":"Focal lesions area feature of chronic inflammatory demyelinating polyneuropathy (CIDP)","volume":"96","author":"Rizzuto","year":"1998","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.bulcan.2019.11.002_bib0270","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1529-8027.2012.00372.x","article-title":"Nodal proteins are target antigens in Guillain-Barr\u00e9 syndrome","volume":"17","author":"Devaux","year":"2012","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.bulcan.2019.11.002_bib0275","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/WCO.0b013e328357a77f","article-title":"Autoantibodies in immune-mediated neuropathies","volume":"25","author":"Chavada","year":"2012","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.bulcan.2019.11.002_bib0280","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1212\/WNL.0000000000000205","article-title":"Neurofascin IgG4\u00a0antibodies in CIDP associate with disabling tremor and poor response to IVIg","volume":"82","author":"Querol","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.bulcan.2019.11.002_bib0285","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/ana.23794","article-title":"Antibodies to contactin-1\u00a0in chronic inflammatory demyelinating polyneuropathy: Contactin-1\u00a0in Aggressive CIDP","volume":"73","author":"Querol","year":"2013","journal-title":"Ann Neurol"},{"key":"10.1016\/j.bulcan.2019.11.002_bib0290","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1212\/WNL.0b013e318245d250","article-title":"CD8+ T-cell immunity in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"78","author":"Schneider-Hohendorf","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.bulcan.2019.11.002_bib0295","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1212\/WNL.0b013e31827debad","article-title":"Recovery of the T-cell repertoire in CIDP by IV immunoglobulins","volume":"80","author":"Mausberg","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.bulcan.2019.11.002_bib0300","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/ana.410360607","article-title":"A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"36","author":"Dyck","year":"1994","journal-title":"Ann Neurol"},{"key":"10.1016\/j.bulcan.2019.11.002_bib0305","first-page":"CD001797","article-title":"Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy","volume":"12","author":"Eftimov","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bulcan.2019.11.002_bib0310","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/ana.1088","article-title":"Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"50","author":"Hughes","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.bulcan.2019.11.002_bib0315","article-title":"Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy","volume":"11","author":"Hughes","year":"2017","journal-title":"Cochrane Database Systc Rev"},{"key":"10.1016\/j.bulcan.2019.11.002_bib0320","first-page":"CD003906","article-title":"Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy","volume":"8","author":"Mehndiratta","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bulcan.2019.11.002_bib0325","article-title":"Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews","volume":"1","author":"Oaklander","year":"2017","journal-title":"Cochrane Database of Syst Rev"},{"key":"10.1016\/j.bulcan.2019.11.002_bib0330","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1136\/jnnp-2013-306105","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy: search for factors associated with treatment dependence or successful withdrawal","volume":"85","author":"Rabin","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.bulcan.2019.11.002_bib0335","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/j.1468-1331.2011.03495.x","article-title":"Immunosuppressive treatment in refractory chronic inflammatory demyelinating polyradiculoneuropathy. A nationwide retrospective analysis: The effect of immunosuppressive treatment in patients with CIDP","volume":"18","author":"Cocito","year":"2011","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.bulcan.2019.11.002_bib0340","article-title":"Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy","volume":"5","author":"Mahdi-Rogers","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bulcan.2019.11.002_bib0345","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1159\/000381767","article-title":"Natalizumab as a disease-modifying therapy in chronic inflammatory demyelinating polyneuropathy \u2013 a report of three cases","volume":"73","author":"Vallat","year":"2015","journal-title":"Eur Neurol"},{"key":"10.1016\/j.bulcan.2019.11.002_bib0350","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1212\/WNL.52.3.498","article-title":"Clinicopathologic findings and prognosis of chronic inflammatory demyelinating polyneuropathy","volume":"52","author":"Bouchard","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.bulcan.2019.11.002_bib0355","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/bmt.2011.185","article-title":"Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation","volume":"47","author":"Snowden","year":"2012","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.bulcan.2019.11.002_bib0360","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/jnnp-2017-316271","article-title":"Autologous haematopoietic stem cell transplantation for neurological diseases","volume":"89","author":"Burman","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.bulcan.2019.11.002_bib0365","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1136\/jnnp-2013-306014","article-title":"Autologous haematopoietic stem cell transplantation: a viable treatment option for CIDP","volume":"85","author":"Press","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.bulcan.2019.11.002_bib0370","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1529-8027.2009.00221.x","article-title":"Autologous peripheral blood stem cell transplantation for chronic acquired demyelinating neuropathy","volume":"14","author":"Mahdi-Rogers","year":"2009","journal-title":"J Peripher Nervous Syst"},{"key":"10.1016\/j.bulcan.2019.11.002_bib0375","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/jnnp.72.1.127","article-title":"Successful autologous stem cell transplantation in a patient with chronic inflammatory demyelinating polyneuropathy","volume":"72","author":"Vermeulen","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.bulcan.2019.11.002_bib0380","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1136\/jnnp.2007.118240","article-title":"Relapse of chronic inflammatory demyelinating polyneuropathy 5\u00a0years after autologous stem cell transplantation","volume":"78","author":"Vermeulen","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.bulcan.2019.11.002_bib0385","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1136\/jnnp.2007.128694","article-title":"Successful repeated treatment with high dose cyclophosphamide and autologous blood stem cell transplantation in CIDP","volume":"79","author":"Axelson","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.bulcan.2019.11.002_bib0390","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1212\/01.wnl.0000277266.53449.8b","article-title":"Nonmyeloablative autologous hematopoietic stem cell transplantation for refractory CIDP","volume":"69","author":"Oyama","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.bulcan.2019.11.002_bib0395","first-page":"249","article-title":"Non-myeloblative autologous hematopoietic stem cell transplantation for chronic inflammatory demyelinating neuropathy treatment","volume":"15","author":"Barreira","year":"2010","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.bulcan.2019.11.002_bib0400","first-page":"S132","article-title":"Autologous peripheral blood progenitor cell transplantation in refractory chronic inflammatory demyelinating polyradiculopathy","volume":"37","author":"Kamat","year":"2006","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.bulcan.2019.11.002_bib0405","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/bmt.2013.18","article-title":"Sj\u00f6gren's syndrome associated chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) treated with autologous and subsequently allogeneic haematopoietic SCT (HSCT)","volume":"48","author":"Bregante","year":"2013","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.bulcan.2019.11.002_bib0410","doi-asserted-by":"crossref","first-page":"S193","DOI":"10.1016\/j.bulcan.2016.09.006","article-title":"[How we harmonize HSCT clinical practices among the SFGM-TC centers]","volume":"103","author":"Tipton","year":"2016","journal-title":"Bull Cancer"},{"key":"10.1016\/j.bulcan.2019.11.002_bib0415","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.clim.2016.06.005","article-title":"Immunological correlates of favorable long-term clinical outcome in multiple sclerosis patients after autologous hematopoietic stem cell transplantation","volume":"169","author":"Arruda","year":"2016","journal-title":"Clin Immunol"},{"key":"10.1016\/j.bulcan.2019.11.002_bib0420","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.neurol.2008.09.001","article-title":"Groupe d\u2019\u00e9tude fran\u00e7ais des PIDC. [Diagnostic strategy for chronic inflammatory demyelinating polyradiculoneuropathy. Recommendations of the French working group]","volume":"164","author":"Magy","year":"2008","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.bulcan.2019.11.002_bib0425","first-page":"115","article-title":"Recommendations on diagnostic strategies for chronic inflammatory demyelinating polyradiculoneuropathy","volume":"79","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.bulcan.2019.11.002_bib0215","doi-asserted-by":"crossref","first-page":"S169","DOI":"10.1016\/j.bulcan.2017.06.019","article-title":"Indications et suivi des autogreffes de cellules souches h\u00e9matopo\u00ef\u00e9tiques dans les maladies auto-immunes et auto-inflammatoires\u00a0: recommandations de la Soci\u00e9t\u00e9 francophone de greffe de moelle et de th\u00e9rapie cellulaire (SFGM-TC)","volume":"104","author":"Pugnet","year":"2017","journal-title":"Bull Cancer"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455119304035?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455119304035?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T19:31:07Z","timestamp":1757791867000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455119304035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0007455119304035"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2019.11.002","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Indications de l\u2019autogreffe de cellules souches h\u00e9matopo\u00ef\u00e9tiques dans la polyradiculon\u00e9vrite inflammatoire d\u00e9my\u00e9linisante chronique\u00a0: recommandations de la Soci\u00e9t\u00e9 francophone de greffe de moelle et de th\u00e9rapie cellulaire (SFGM-TC)","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2019.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}